Physician profile
Steven Wolf
NPI 1457339046
$3,965.51
in general payments reported to CMS, 2019-2025
10 companies · $3,540 in 2025
The $3,540 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2022: $75.77 · 2025: $3,540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,540.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $3,540.00 | 2025 | Epidiolex |
| Novartis Pharmaceuticals Corporation | $143.76 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $120.12 | 2019 | |
| Abbvie INC. | $33.65 | 2022 | |
| Genentech USA, INC. | $32.84 | 2019 | |
| Alexion Pharmaceuticals, INC. | $27.83 | 2019 | |
| Allergan, INC. | $22.53 | 2022 | |
| Amgen INC. | $19.59 | 2022 | |
| Genzyme Corporation | $13.16 | 2019 | |
| Biogen, INC. | $12.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.